Drug Profile
Malaria vaccine (FMP012) - Walter Reed Army Institute of Research/US Army Medical Research and Materiel Command
Alternative Names: Falciparum malaria protein-12 vaccine; FMP012; FMP012 subunit malaria vaccine - WRAIR; FMP012/AS01B malaria vaccine; Malaria vaccine PfCelTOS WRAIR; Malaria vaccine recombinant FMP012; Plasmodium falciparum FMP012 vaccine; Plasmodium falciparum PfCelTOS vaccine; Plasmodium falciparum vaccine FMP012; Recombinant FMP012 malaria vaccineLatest Information Update: 16 Aug 2023
Price :
$50
*
At a glance
- Originator United States Army Medical Research and Materiel Command; Walter Reed Army Institute of Research
- Class Antimalarials; Parasitic vaccines; Subunit vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Malaria(Prevention, In volunteers) in USA (IM, Injection)
- 11 Jun 2014 Preclinical trials in Malaria (Prevention) in USA (IM)
- 11 Jun 2014 Walter Reed Army Institute of Research and US Army Medical Research and Materiel Command plan a phase I trial for Malaria (Prevention) in USA (NCT02174978)